Min Li
Direktor/Vorstandsmitglied bei ADAGENE INC.
Aktive Positionen von Min Li
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADAGENE INC. | Direktor/Vorstandsmitglied | 08.02.2021 | - |
Independent Dir/Board Member | 08.02.2021 | - | |
LAEKNA, INC. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
Scineuro Pharmaceuticals
Scineuro Pharmaceuticals BiotechnologyHealth Technology SciNeuro Pharmaceuticals is a Chinese clinical-stage biotechnology company that focuses on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. SciNeuro Pharmaceuticals is based in Shanghai, China, and has corporate and R&D facilities located in both Shanghai and Beijing. SciNeuro has built a portfolio of pipeline programs that address three key disease-driving mechanisms of neurodegeneration. The company is committed to delivering medicines that can make a difference in the lives of patients around the world. The company is an innovation-driven, neuroscience-focused biopharmaceutical company that uses in-house discovery and development to create innovative therapeutics for neurodegenerative and other CNS diseases. The company was founded in 2020 by Min Li, who has been the CEO since then. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Vorstandsvorsitzender | 01.01.2020 | - | |
Gründer | 01.01.2020 | - | |
Novotech Health Holdings Ltd.
Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Direktor/Vorstandsmitglied | 01.05.2021 | - |
Independent Dir/Board Member | 01.05.2021 | - |
Karriereverlauf von Min Li
Ehemalige bekannte Positionen von Min Li
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lilly Asia Ventures (Hongkong) | Corporate Officer/Principal | 01.07.2019 | 01.01.2020 |
GSK PLC | Corporate Officer/Principal | 01.01.2013 | 01.03.2019 |
The Johns Hopkins University School of Medicine | Corporate Officer/Principal | 01.03.1993 | 01.01.2013 |
Ausbildung von Min Li
Wuhan University | Undergraduate Degree |
The Johns Hopkins University | Doctorate Degree |
Statistik
International
China | 5 |
Vereinigte Staaten | 3 |
Hong Kong | 3 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ADAGENE INC. | Health Technology |
GSK PLC | Health Technology |
LAEKNA, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Scineuro Pharmaceuticals
Scineuro Pharmaceuticals BiotechnologyHealth Technology SciNeuro Pharmaceuticals is a Chinese clinical-stage biotechnology company that focuses on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. SciNeuro Pharmaceuticals is based in Shanghai, China, and has corporate and R&D facilities located in both Shanghai and Beijing. SciNeuro has built a portfolio of pipeline programs that address three key disease-driving mechanisms of neurodegeneration. The company is committed to delivering medicines that can make a difference in the lives of patients around the world. The company is an innovation-driven, neuroscience-focused biopharmaceutical company that uses in-house discovery and development to create innovative therapeutics for neurodegenerative and other CNS diseases. The company was founded in 2020 by Min Li, who has been the CEO since then. | Health Technology |
Novotech Health Holdings Ltd.
Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Health Technology |
Lilly Asia Ventures (Hongkong) |